Physiotherapy Management of Type 1 Diabetes Mellitus
Adults with type 1 diabetes should engage in at least 150 minutes per week of moderate-to-vigorous aerobic exercise spread over at least 3 days (with no more than 2 consecutive rest days), combined with 2-3 sessions per week of resistance training on nonconsecutive days, while implementing specific glucose monitoring and carbohydrate/insulin adjustment protocols to prevent hypoglycemia. 1
Core Exercise Prescription
Aerobic Training
- Target 150 minutes weekly of moderate-to-vigorous intensity aerobic activity, distributed across at least 3 days with no more than 2 consecutive days without exercise to maintain insulin sensitivity 1
- For younger, physically fit individuals, a minimum of 75 minutes weekly of vigorous-intensity or interval training is sufficient 1
- Each aerobic session should last at least 10 minutes, building toward 30 minutes per session 2
- Daily exercise is optimal since insulin resistance benefits dissipate within 48-72 hours without activity 3
Resistance Training
- Perform 2-3 sessions weekly on nonconsecutive days 1
- Each session should include at least one set of five or more different exercises targeting large muscle groups 1
- Resistance training of any intensity improves strength, balance, and ability to perform daily activities 1
- Heavy resistance training with free weights or machines may provide additional glycemic control benefits 1
Flexibility and Balance Training
- Implement 2-3 sessions weekly of flexibility and balance exercises 1
- Yoga and tai chi are acceptable modalities that improve flexibility, muscle strength, and balance 1
- These exercises are particularly important for older adults to maintain range of motion and prevent falls 1
Sedentary Behavior Interruption
- Break up prolonged sitting every 30 minutes with brief standing, walking, or light physical activity for blood glucose benefits 1
- Encourage non-exercise physical activities including walking, yoga, housework, gardening, swimming, and dancing above baseline levels 1
Critical Safety Protocols for Hypoglycemia Prevention
Pre-Exercise Glucose Monitoring
- Check blood glucose before every exercise session 2, 4
- If pre-exercise glucose is <90 mg/dL (5.0 mmol/L), ingest additional carbohydrate before starting exercise 1
- The amount of carbohydrate needed depends on insulin dose adjustments, time of day, and exercise intensity/duration 1
Insulin Dose Adjustments
- Reduce insulin doses prior to exercise for those using insulin pumps or taking pre-exercise insulin injections 1
- Some insulin is typically still needed even with dose reductions 5
- Patients must be educated on specific insulin modification strategies based on their regimen 2
Post-Exercise Monitoring
- Monitor glucose frequently after exercise to detect delayed hypoglycemia, which can occur several hours post-exercise due to increased insulin sensitivity 1
- This prolonged monitoring is especially critical for those with hypoglycemia unawareness or after high-intensity exercise 5
Carbohydrate Adjustment Protocols
- Medication dose or carbohydrate consumption must be adjusted for each exercise bout and its post-bout impact 1
- Patients should carry glucose tablets or gel during exercise sessions 5
- Exercise with a partner who is aware of diabetes management needs 5
Exercise Contraindications and Precautions
Proliferative Retinopathy
- Vigorous-intensity aerobic or resistance exercise may be contraindicated if proliferative diabetic retinopathy or severe nonproliferative diabetic retinopathy is present due to risk of vitreous hemorrhage or retinal detachment 1
- Consultation with an ophthalmologist is appropriate before engaging in intense exercise regimens 1
Peripheral Neuropathy
- Decreased pain sensation and higher pain thresholds increase risk of skin breakdown, infection, and Charcot joint development 1
- Proper foot care is critical, including appropriate footwear selection, regular skin inspection, and evaluation/treatment of calluses and lesions 5
- Consider alternatives to weight-bearing exercises for those with severe neuropathy 5
Cardiovascular Assessment
- Perform careful history and assess cardiovascular risk factors before initiating moderate-to-vigorous exercise programs 1
- Those with high cardiovascular risk should start with short periods of low-intensity exercise and slowly increase intensity and duration as tolerated 1
- Exercise tolerance testing can identify anginal thresholds and asymptomatic ischemia 5
Special Considerations for Glycemic Response
Variable Individual Responses
- Each individual with type 1 diabetes has a variable glycemic response to exercise that must be taken into consideration when recommending exercise type and duration 1
- Intense activities may actually raise blood glucose levels instead of lowering them, especially if pre-exercise glucose levels are already elevated 1, 2
- This variability requires individualized education on glucose monitoring timing and adjustment protocols 2
Cardiovascular and Mortality Benefits
- Higher amounts of physical activity reduce cardiovascular mortality after mean follow-up of 11.4 years in patients with and without chronic kidney disease 1
- A dose-response inverse relationship exists between physical activity frequency and A1C, BMI, hypertension, dyslipidemia, and diabetes-related complications including retinopathy and microalbuminuria 1
- Regular exercise improves cardiovascular fitness, muscle strength, insulin sensitivity, triglyceride levels, LDL cholesterol, waist circumference, and body mass 1
Common Pitfalls to Avoid
- Never allow more than 2 consecutive days between exercise sessions, as insulin sensitivity benefits dissipate rapidly 1
- Do not assume exercise will always lower blood glucose—intense exercise can raise glucose if pre-exercise levels are elevated 1, 2
- Avoid inadequate post-exercise monitoring—hypoglycemia can occur hours after exercise completion 1
- Do not neglect foot inspection and proper footwear, especially in patients with peripheral neuropathy 1, 5
- Never initiate vigorous exercise without ophthalmology clearance in patients with known or suspected proliferative retinopathy 1